DelveInsight has launched a new report on Medulloblastoma Epidemiology
Medulloblastoma is classified as a primitive neuroectodermal tumor, typically occurring in the cerebellar vermis which is located in the posterior fossa of the skull. This tumor accounts for 40% of those arising from the posterior fossa.
Request for free sample copy- https://www.delveinsight.com/sample-request/medulloblastoma-market
Medulloblastoma Epidemiology historical as well as forecasted Medulloblastoma epidemiology in 7MM, covering the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan from 2018 to 2030
Medulloblastoma Epidemiology
According to Orphanet, Medulloblastoma (MB) is the most common malignant brain tumor in childhood. Annual incidence varies according to age a group, and is estimated in the USA at 0.47/100,000 in children (0-14 years of age), 0.11/100,000 in adolescents and young adults, 0.02/100,000 in adults (over 40 years of age). Males are more affected than females
Key facts of Medulloblastoma Epidemiology
Medulloblastoma Epidemiology Segmentation
Medulloblastoma Symptoms
The symptoms of medulloblastoma usually result from increased pressure within the skull (intracranial pressure). Many infants and children develop papilledema, a condition in which the optic nerve swells because of increased intracranial pressure. Additional symptoms may include irritability, increased head size, and paralysis (paresis) of the muscles that help control eye movements (extraocular muscles).
Medulloblastoma Report Scope
Table of content
1. Key Insights
2. Executive Summary of Medulloblastoma
3. Competitive Intelligence Analysis for Medulloblastoma
4. Medulloblastoma: Market Overview at a Glance
5. Medulloblastoma: Disease Background and Overview
6. Patient Journey
7. Medulloblastoma Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Medulloblastoma Treatment
11. Marketed Products
12. Emerging Therapies
13. Medulloblastoma: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Medulloblastoma
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
What will be the key questions answered?
Reasons to buy
Related Reports
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Yash BhardwajEmail: Send EmailPhone: +919650213330Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/